A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.
Journal
American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
accepted:
15
06
2021
pubmed:
5
8
2021
medline:
14
1
2022
entrez:
4
8
2021
Statut:
ppublish
Résumé
Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent. The main goals of treatment are reducing symptoms and preventing disease progression and further hair loss. Currently, the literature has limited evidence on treatments for this difficult condition, and most available evidence is from case reports and case series. Furthermore, the evidence shows a varied response to therapy, with frequent reports of poor response. This article reviews the diagnosis of this rare disease, summarize the currently available treatments, and provide insights and practices from alopecia experts.
Identifiants
pubmed: 34347282
doi: 10.1007/s40257-021-00630-7
pii: 10.1007/s40257-021-00630-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
681-692Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Babahosseini H, Tavakolpour S, Mahmoudi H, Balighi K, Teimourpour A, Ghodsi SZ, et al. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients. J Dermatol Treat. 2019;30(6):598–604. https://doi.org/10.1080/09546634.2018.1542480 .
doi: 10.1080/09546634.2018.1542480
Kang H, Alzolibani AA, Otberg N, Shapiro J. Lichen planopilaris. Dermatol Ther. 2008;21(4):249–56. https://doi.org/10.1111/j.1529-8019.2008.00206.x .
doi: 10.1111/j.1529-8019.2008.00206.x
pubmed: 18715294
Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009;28(1):3–10. https://doi.org/10.1016/j.sder.2008.12.006 .
doi: 10.1016/j.sder.2008.12.006
pubmed: 19341936
Errichetti E, Figini M, Croatto M, Stinco G. Therapeutic management of classic lichen planopilaris: a systematic review. Clin Cosmet Investig Dermatol. 2018;11:91–102. https://doi.org/10.2147/CCID.S137870 .
doi: 10.2147/CCID.S137870
pubmed: 29520159
pmcid: 5833781
Trager MH, Lavian J, Lee EY, Gary D, Jenkins F, Christiano AM, et al. Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York city health care system. J Am Acad Dermatol. 2021;84(4):1166–9. https://doi.org/10.1016/j.jaad.2020.10.081 .
doi: 10.1016/j.jaad.2020.10.081
pubmed: 33137442
Ochoa BE, King LE Jr, Price VH. Lichen planopilaris: Annual incidence in four hair referral centers in the United States. J Am Acad Dermatol. 2008;58(2):352–3. https://doi.org/10.1016/j.jaad.2007.11.007 .
doi: 10.1016/j.jaad.2007.11.007
pubmed: 18222337
Lepe K, Nassereddin A, Salazar FJ. Lichen Planopilaris. Treasure Island: StatPearls Publishing; 2021.
Aldoori N, Dobson K, Holden CR, McDonagh AJ, Harries M, Messenger AG. Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol. 2016;175(4):762–7. https://doi.org/10.1111/bjd.14535 .
doi: 10.1111/bjd.14535
pubmed: 26987767
Lee JA, Levy DA, Patel KG, Brennan E, Oyer SL. Hair transplantation in frontal fibrosing alopecia and lichen planopilaris: a systematic review. Laryngoscope. 2021;131(1):59–66. https://doi.org/10.1002/lary.28551 .
doi: 10.1002/lary.28551
pubmed: 32045028
Chiang YZ, Tosti A, Chaudhry IH, Lyne L, Farjo B, Farjo N, et al. Lichen planopilaris following hair transplantation and face-lift surgery. Br J Dermatol. 2012;166(3):666–370. https://doi.org/10.1111/j.1365-2133.2011.10692.x .
doi: 10.1111/j.1365-2133.2011.10692.x
pubmed: 21985326
Monselise A, Chan LJ, Shapiro J. Break dancing: a new risk factor for scarring hair loss. J Cutan Med Surg. 2011;15(3):177–9. https://doi.org/10.2310/7750.2011.10032 .
doi: 10.2310/7750.2011.10032
pubmed: 21561588
Bolduc C, Sperling LC, Shapiro J. Primary cicatricial alopecia: lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. J Am Acad Dermatol. 2016;75(6):1081–99. https://doi.org/10.1016/j.jaad.2014.09.058 .
doi: 10.1016/j.jaad.2014.09.058
pubmed: 27846944
Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57(1):47–53. https://doi.org/10.1016/j.jaad.2007.01.011 .
doi: 10.1016/j.jaad.2007.01.011
pubmed: 17467854
Manatis-Lornell A, Okhovat JP, Marks DH, Hagigeorges D, Senna MM. Comorbidities in patients with lichen planopilaris: a retrospective case-control study. J Am Acad Dermatol. 2020;83(1):205–8. https://doi.org/10.1016/j.jaad.2019.07.018 .
doi: 10.1016/j.jaad.2019.07.018
pubmed: 31306727
Larkin SC, Cantwell HM, Imhof RL, Torgerson RR, Tolkachjov SN. Lichen planopilaris in women: a retrospective review of 232 women seen at mayo clinic from 1992 to 2016. Mayo Clin Proc. 2020;95(8):1684–95. https://doi.org/10.1016/j.mayocp.2020.02.028 .
doi: 10.1016/j.mayocp.2020.02.028
pubmed: 32753140
Soares VC, Mulinari-Brenner F, Souza TE. Lichen planopilaris epidemiology: a retrospective study of 80 cases. An Bras Dermatol. 2015;90(5):666–70. https://doi.org/10.1590/abd1806-4841.20153923 .
doi: 10.1590/abd1806-4841.20153923
pubmed: 26560212
pmcid: 4631232
Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387–92. https://doi.org/10.1016/j.jaad.2009.08.054 .
doi: 10.1016/j.jaad.2009.08.054
pubmed: 20061052
Crisóstomo MR, Crisóstomo MC, Crisóstomo MG, Gondim VJ, Crisóstomo MR, Benevides AN. Hair loss due to lichen planopilaris after hair transplantation: a report of two cases and a literature review. An Bras Dermatol. 2011;86(2):359–62. https://doi.org/10.1590/s0365-05962011000200024 .
doi: 10.1590/s0365-05962011000200024
pubmed: 21603824
Morais KL, Martins CF, Anzai A, Valente NYS, Romiti R. Lichen planopilaris with pustules: a diagnostic challenge. Skin Appendage Disord. 2018;4(2):61–6. https://doi.org/10.1159/000478268 .
doi: 10.1159/000478268
pubmed: 29765960
Donovan J. Lichen planopilaris after hair transplantation: report of 17 cases. Dermatol Surg. 2012;38(12):1998–2004. https://doi.org/10.1111/dsu.12014 .
doi: 10.1111/dsu.12014
pubmed: 23205573
Baquerizo Nole KL, Nusbaum B, Pinto GM, Miteva M. Lichen planopilaris in the androgenetic alopecia area: a pitfall for hair transplantation. Skin Appendage Disord. 2015;1(1):49–53. https://doi.org/10.1159/000381588 .
doi: 10.1159/000381588
pubmed: 27171849
pmcid: 4857822
Lajevardi V, Mahmoudi H, Moghanlou S, Ansari M, Teimourpour A, Daneshpazhooh M. Assessing the correlation between trichoscopic features in lichen planopilaris and lichen planopilaris activity index. Australas J Dermatol. 2019;60(3):214–8. https://doi.org/10.1111/ajd.13022 .
doi: 10.1111/ajd.13022
pubmed: 30957880
Nirmal B, George R, Kodiatte TA. Invisible lichen planopilaris unmasked by dermatoscopy. Int J Trichol. 2017;9(2):76–8. https://doi.org/10.4103/ijt.ijt_81_16 .
doi: 10.4103/ijt.ijt_81_16
Jain N, Doshi B, Khopkar U. Trichoscopy in alopecias: diagnosis simplified. Int J Trichol. 2013;5(4):170–8. https://doi.org/10.4103/0974-7753.130385 .
doi: 10.4103/0974-7753.130385
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1–12. https://doi.org/10.1016/j.jaad.2017.04.1141 .
doi: 10.1016/j.jaad.2017.04.1141
pubmed: 29241771
Callender VD, Lawson CN, Onwudiwe OC. Hair transplantation in the surgical treatment of central centrifugal cicatricial alopecia. Dermatol Surg. 2014;40(10):1125–31. https://doi.org/10.1097/dss.0000000000000127 .
doi: 10.1097/dss.0000000000000127
pubmed: 25207763
Karadağ AS, Parish LC. Sarcoidosis: a great imitator. Clin Dermatol. 2019;37(3):240–54. https://doi.org/10.1016/j.clindermatol.2019.01.005 .
doi: 10.1016/j.clindermatol.2019.01.005
pubmed: 31178106
Katta R, Nelson B, Chen D, Roenigk H. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol. 2000;42(4):690–2.
doi: 10.1067/mjd.2000.104679
Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol. 2007;25(3):276–87. https://doi.org/10.1016/j.clindermatol.2007.03.004 .
doi: 10.1016/j.clindermatol.2007.03.004
pubmed: 17560305
Prohaska J, Demaree E, Powers J, Cook C. Scalp sarcoidosis presenting as cicatricial alopecia. J Am Osteopath Assoc. 2018;118(12):824–6. https://doi.org/10.7556/jaoa.2018.175 .
doi: 10.7556/jaoa.2018.175
pubmed: 30476994
Knight L, Ngwanya M. Sarcoidosis of the scalp: the largest single-institutional case series. Int J Dermatol. 2019;58(8):e149–51. https://doi.org/10.1111/ijd.14483 .
doi: 10.1111/ijd.14483
pubmed: 31115900
Kreutzer KM, Effendy I. Cicatricial alopecia related to folliculotropic mycosis fungoides. Dermatol Ther (Heidelb). 2020;10(5):1175–80. https://doi.org/10.1007/s13555-020-00429-0 .
doi: 10.1007/s13555-020-00429-0
pubmed: 32833161
pmcid: 7477037
Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, et al. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome. J Am Acad Dermatol. 2011;64(1):53–63. https://doi.org/10.1016/j.jaad.2009.12.056 .
doi: 10.1016/j.jaad.2009.12.056
pubmed: 21036417
Nasimi M, Ahangari N, Lajevardi V, Mahmoudi H, Ghodsi SZ, Etesami I. Quality of life and mental health status in patients with lichen planopilaris based on Dermatology Life Quality Index and General Health Questionnaire-28 questionnaires. Int J Womens Dermatol. 2020;6(5):399–403. https://doi.org/10.1016/j.ijwd.2020.09.005 .
doi: 10.1016/j.ijwd.2020.09.005
pubmed: 33898707
pmcid: 8060658
Alirezaei P, Ahmadpanah M, Rezanejad A, Soltanian A, Sadeghi Bahmani D, Brand S. Compared to controls, individuals with lichen planopilaris have more depression, a lower self-esteem, and a lower quality of life. Neuropsychobiology. 2019;78(2):95–103. https://doi.org/10.1159/000499135 .
doi: 10.1159/000499135
pubmed: 30970367
Kerkemeyer KL, Green J. Lichen planopilaris: a retrospective study of 32 cases in an Australian tertiary referral hair clinic. Australas J Dermatol. 2018;59(4):297–301. https://doi.org/10.1111/ajd.12772 .
doi: 10.1111/ajd.12772
pubmed: 29297588
Vano-Galvan S, Trindadedearvalho L, Saceda-Corralo D, Rodrigues-Barata R, Kerkemeyer KL, Sinclair RD, et al. Oral minoxidil improves background hair thickness in lichen planopilaris. J Am Acad Dermatol. 2021;84(6):1684–6. https://doi.org/10.1016/j.jaad.2020.04.026 .
doi: 10.1016/j.jaad.2020.04.026
pubmed: 32289397
Bergfeld W, Washenik K, Callender V, Zhang P, Quiza C, Doshi U, et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. J Drugs Dermatol. 2016;15(7):874–81.
pubmed: 27391639
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377–85. https://doi.org/10.1067/mjd.2002.124088 .
doi: 10.1067/mjd.2002.124088
pubmed: 12196747
Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol. 2014;59(5):456–9. https://doi.org/10.4103/0019-5154.139872 .
doi: 10.4103/0019-5154.139872
pubmed: 25284849
pmcid: 4171912
Lyakhovitsky A, Amichai B, Sizopoulou C, Barzilai A. A case series of 46 patients with lichen planopilaris: demographics, clinical evaluation, and treatment experience. J Dermatol Treat. 2015;26(3):275–9. https://doi.org/10.3109/09546634.2014.933165 .
doi: 10.3109/09546634.2014.933165
Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27(6 Pt 1):935–42. https://doi.org/10.1016/0190-9622(92)70290-v .
doi: 10.1016/0190-9622(92)70290-v
pubmed: 1479098
Akiyama M, Smith LT, Holbrook KA. Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol. 1996;106(3):391–6. https://doi.org/10.1111/1523-1747.ep12343381 .
doi: 10.1111/1523-1747.ep12343381
pubmed: 8648166
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014;2014:760709. https://doi.org/10.1155/2014/760709 .
doi: 10.1155/2014/760709
pubmed: 24883322
pmcid: 4032742
Yin L, Svigos K, Lo Sicco K, Shapiro J. Platelet-rich plasma. In: Alves R, Grimalt R, editors. Techniques in the evaluation and management of hair diseases. Boca Raton: CRC Press; 2021.
Bolanca Z, Goren A, Getaldic-Svarc B, Vucic M, Situm M. Platelet-rich plasma as a novel treatment for lichen planopillaris. Dermatol Ther. 2016;29(4):233–5. https://doi.org/10.1111/dth.12343 .
doi: 10.1111/dth.12343
pubmed: 26988129
Dina Y, Aguh C. Use of platelet-rich plasma in cicatricial alopecia. Dermatol Surg. 2019;45(7):979–81. https://doi.org/10.1097/DSS.0000000000001635 .
doi: 10.1097/DSS.0000000000001635
pubmed: 30148733
Jha AK. Platelet-rich plasma for the treatment of lichen planopilaris. J Am Acad Dermatol. 2018;79(5):e95–6. https://doi.org/10.1016/j.jaad.2018.05.029 .
doi: 10.1016/j.jaad.2018.05.029
pubmed: 29807058
Özcan D, Tunçer Vural A, Özen Ö. Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report. Dermatol Ther. 2019;32(5):e13072. https://doi.org/10.1111/dth.13072 .
doi: 10.1111/dth.13072
pubmed: 31443128
Svigos K, Yin L, Shaw K, Gutierrez D, Peterson E, Lo Sicco K, et al. Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization. J Am Acad Dermatol. 2020;83(5):1506–9. https://doi.org/10.1016/j.jaad.2020.06.026 .
doi: 10.1016/j.jaad.2020.06.026
pubmed: 32553684
Nichonncha E, Foley CC, Markham T. The role of hydroxychloroquine in the treatment of lichen planopilaris: a retrospective case series and review. Dermatol Ther. 2017. https://doi.org/10.1111/dth.12463 .
doi: 10.1111/dth.12463
Naeini FF, Saber M, Asilian A, Hosseini SM. Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: a randomized clinical trial. Int J Prev Med. 2017;8:37. https://doi.org/10.4103/ijpvm.IJPVM_156_17 .
doi: 10.4103/ijpvm.IJPVM_156_17
pubmed: 28584619
pmcid: 5450502
Geamănu Pancă A, Popa-Cherecheanu A, Marinescu B, Geamănu CD, Voinea LM. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review. J Med Life. 2014;7(3):322–6.
pubmed: 25408748
pmcid: 4233433
Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF; American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–94. https://doi.org/10.1016/j.ophtha.2016.01.058 .
doi: 10.1016/j.ophtha.2016.01.058
pubmed: 26992838
Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–60. https://doi.org/10.1001/jamaophthalmol.2014.3459 .
doi: 10.1001/jamaophthalmol.2014.3459
pubmed: 25275721
Henehan M, Montuno M, De Benedetto A. Doxycycline as an anti-inflammatory agent: updates in dermatology. J Eur Acad Dermatol Venereol. 2017;31(11):1800–8. https://doi.org/10.1111/jdv.14345 .
doi: 10.1111/jdv.14345
pubmed: 28516469
Patel RS, Parmar M. Doxycycline hyclate. Treasure Island: StatPearls Publishing; 2021.
Spring P, Spanou Z, de Viragh PA. Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. J Am Acad Dermatol. 2013;69(5):830–2. https://doi.org/10.1016/j.jaad.2013.04.066 .
doi: 10.1016/j.jaad.2013.04.066
pubmed: 24124823
Mardones F, Shapiro J. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience. Clin Exp Dermatol. 2017;42(7):755–9. https://doi.org/10.1111/ced.13203 .
doi: 10.1111/ced.13203
pubmed: 28748570
Iamsumang W, Leerunyakul K, Suchonwanit P. Finasteride and its potential for the treatment of female pattern hair loss: evidence to date. Drug Des Dev Ther. 2020;14:951–9. https://doi.org/10.2147/dddt.S240615 .
doi: 10.2147/dddt.S240615
Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-41.e5. https://doi.org/10.1016/j.jaad.2017.02.054 .
doi: 10.1016/j.jaad.2017.02.054
pubmed: 28396101
Zito PM, Bistas KG, Syed K. Finasteride. Treasure Island: StatPearls Publishing; 2021.
Oliveira-Soares R, André MC, Peres-Correia M. Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women. Int J Trichol. 2018;10(1):48–50. https://doi.org/10.4103/ijt.ijt_73_15 .
doi: 10.4103/ijt.ijt_73_15
Mirmirani P, Karnik P. Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol. 2009;145(12):1363–6. https://doi.org/10.1001/archdermatol.2009.283 .
doi: 10.1001/archdermatol.2009.283
pubmed: 20026843
pmcid: 2937154
George SJ, Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol. 2001;45(6):965–6. https://doi.org/10.1067/mjd.2001.119559 .
doi: 10.1067/mjd.2001.119559
pubmed: 11712051
Hodgens A, Sharman T. Corticosteroids. Treasure Island: StatPearls Publishing; 2021.
Peterson EL, Gutierrez D, Brinster NK, Lo Sicco KI, Shapiro J. Response of lichen planopilaris to pioglitazone hydrochloride. J Drugs Dermatol. 2019;18(12):1276–9.
pubmed: 31860218
Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol. 2009;129(5):1243–57. https://doi.org/10.1038/jid.2008.369 .
doi: 10.1038/jid.2008.369
pubmed: 19052558
Spring P, Spanou Z, de Viragh PA. Lichen planopilaris treated by the peroxisome proliferator activated receptor-gamma agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. J Am Acad Dermatol. 2013;69(5):830–2. https://doi.org/10.1016/j.jaad.2013.04.066 .
doi: 10.1016/j.jaad.2013.04.066
pubmed: 24124823
Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019;80(6):1746–52. https://doi.org/10.1016/j.jaad.2018.12.031 .
doi: 10.1016/j.jaad.2018.12.031
pubmed: 30582992
Strazzulla LC, Avila L, Lo Sicco K, Shapiro J. Novel treatment using low-dose naltrexone for lichen planopilaris. J Drugs Dermatol. 2017;16(11):1140–2.
pubmed: 29141063
Lajevardi V, Salarvand F, Ghiasi M, Nasimi M, Taraz M. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial. J Dermatol Treat. 2020. https://doi.org/10.1080/09546634.2020.1774488 (Epub 8 Jun 2020).
doi: 10.1080/09546634.2020.1774488
Pile HD, Sadiq NM. Isotretinoin. Treasure Island: StatPearls Publishing; 2021.
Spano F, Donovan JC. Efficacy of oral retinoids in treatment-resistant lichen planopilaris. J Am Acad Dermatol. 2014;71(5):1016–8. https://doi.org/10.1016/j.jaad.2014.06.013 .
doi: 10.1016/j.jaad.2014.06.013
pubmed: 25437967
Fatemi F, Mohaghegh F, Danesh F, Saber M, Rajabi P. Isotretinoin for the treatment of facial lichen planopilaris: a new indication for an old drug, a case series study. Clin Case Rep. 2020;8(12):2524–9. https://doi.org/10.1002/ccr3.3210 .
doi: 10.1002/ccr3.3210
pubmed: 33363772
pmcid: 7752461
Mostafa N, Phan K, Smith S. Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis. J Dermatol Treat. 2020. https://doi.org/10.1080/09546634.2020.1755416 (Epub 23 Apr 2020).
doi: 10.1080/09546634.2020.1755416
CellCept [package insert]. Roche Laboratories Inc; 2000.
Hannoodee M, Mittal M. Methotrexate. Treasure Island: StatPearls Publishing; 2021.
Bulbul Baskan E, Yazici S. Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy? Cutan Ocul Toxicol. 2018;37(2):196–9. https://doi.org/10.1080/15569527.2017.1382503 .
doi: 10.1080/15569527.2017.1382503
pubmed: 28944688
Fatemi Naeini F, Mohaghegh F, Jelvan M, Asilian A, Saber M. Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris? A comparative clinical trial. Int Immunopharmacol. 2020;86:106765. https://doi.org/10.1016/j.intimp.2020.106765 .
doi: 10.1016/j.intimp.2020.106765
pubmed: 32674048
Safarini OA, Patel J. Calcineurin inhibitors. Treasure Island: StatPearls Publishing; 2021.
Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49(4):667–71. https://doi.org/10.1067/s0190-9622(03)00873-9 .
doi: 10.1067/s0190-9622(03)00873-9
pubmed: 14512914
Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42(5):342–5. https://doi.org/10.1046/j.1365-4362.2003.01695.x .
doi: 10.1046/j.1365-4362.2003.01695.x
pubmed: 12755968
Yang CC, Khanna T, Sallee B, Christiano AM, Bordone LA. Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatol Ther. 2018;31(6):12656. https://doi.org/10.1111/dth.12656 .
doi: 10.1111/dth.12656
Batra P, Sukhdeo K, Shapiro J. Hair loss in lichen planopilaris and frontal fibrosing alopecia: not always irreversible. Skin Appendage Disord. 2020;6(2):125–9. https://doi.org/10.1159/000505439 .
doi: 10.1159/000505439
pubmed: 32258058
pmcid: 7109433
Harigai M. Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis. Rheumatol (Oxf). 2019;58(Suppl 1):i34–42. https://doi.org/10.1093/rheumatology/key287 .
doi: 10.1093/rheumatology/key287
Phillips TG, Slomiany WP, Allison R. Hair loss: common causes and treatment. Am Fam Phys. 2017;96(6):371–8.
Liu YS, Jee SH, Chan JL. Hair transplantation for the treatment of lichen planopilaris and frontal fibrosing alopecia: a report of two cases. Australas J Dermatol. 2018;59(2):e118–22. https://doi.org/10.1111/ajd.12682 .
doi: 10.1111/ajd.12682
pubmed: 28736812
Dahdah MJ, Iorizzo M. The role of hair restoration surgery in primary cicatricial alopecia. Skin Appendage Disord. 2016;2(1–2):57–60. https://doi.org/10.1159/000448104 .
doi: 10.1159/000448104
pubmed: 27843925
pmcid: 5096151
Unger W, Unger R, Wesley C. The surgical treatment of cicatricial alopecia. Dermatol Ther. 2008;21(4):295–311. https://doi.org/10.1111/j.1529-8019.2008.00211.x .
doi: 10.1111/j.1529-8019.2008.00211.x
pubmed: 18715299
Jiménez F. Commentary: lichen planopilaris after hair transplantation. Dermatol Surg. 2012;38(12):2005. https://doi.org/10.1111/j.1524-4725.2012.02578.x .
doi: 10.1111/j.1524-4725.2012.02578.x
pubmed: 23205545